Centivax, Inc.
PrivateLast Round
Early Funding
Mar 30, 2026
Total Funding Raised
$116.99M
Momentum Score
25 /100
Company Overview
Centivax, Inc. is a biotechnology company that deploys a proprietary computational immune-engineering platform to create universal vaccines and therapies for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centivax, Inc. Comps
Public and private peers based on sector, stage, and business model.
Centivax, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 30, 2026 | ||||
| Grant | Jul 8, 2025 | ||||
| Series A | Jul 8, 2025 | ||||
| Seed | Nov 16, 2022 | ||||
| Grant | Nov 1, 2019 |
Key People
Founding team and executive leadership
Centivax, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Series A, Early Funding |
| NFX | Series A, Seed |
| Future Ventures | Series A |
| CEPI | Grant |
| NIH RADx | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Base4 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$37M raised in early funding round.
- Mar 30, 2026
Developing a next-generation universal vaccine platform with support from Meiji Seika Pharma.
Centivax, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centivax, Inc.'s valuation, stock price, and market status.
